Aspire Biopharma Holdings, Inc.
ASBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.
Other share classesASBPW
13F holders, Q4 2023
Institutional positions in Aspire Biopharma Holdings, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- 0 vs. Q3 2023
- Shares held
- 1.72M
- +833 (0.0%) vs. Q3 2023
- Total value
- $17.9M
- −$289.2K (−1.6%) vs. Q3 2023
- New holders
- 3
- 3 more added
- Sold out
- 3
- 5 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $250.9K |
| Q1 2026 | 15 | $371.9K |
| Q4 2025 | 30 | $899.8K |
| Q3 2025 | 25 | $645.6K |
| Q2 2025 | 16 | $544.7K |
| Q1 2025 | 15 | $875.8K |
| Q4 2024 | 3 | $5.36M |
| Q3 2024 | 2 | $149.6K |
| Q2 2024 | 3 | $90.4K |
| Q1 2024 | 19 | $18.1M |
| Q4 2023 | 21 | $17.9M |
| Q3 2023 | 21 | $18.2M |
| Q2 2023 | 14 | $17.0M |
| Q1 2023 | 59 | $267.9M |
| Q4 2022 | 57 | $264.7M |
| Q3 2022 | 61 | $260.8M |
| Q2 2022 | 54 | $243.4M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Aspire Biopharma Holdings, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fir Tree Capital Management LP | 180,978 | $1.97M | 0.43% | +34,462+23.5% | Added |
| Periscope Capital Inc. | 175,000 | $1.91M | 0.32% | −26,050−13.0% | Reduced |
| Hudson Bay Capital Management LP | 150,000 | $1.64M | 0.01% | 00.0% | Unchanged |
| Arena Investors LP | 150,000 | $1.64M | 10.43% | 00.0% | Unchanged |
| CNH Partners LLC | 150,000 | $1.64M | 0.07% | 00.0% | Unchanged |
| LMR Partners LLP | 150,000 | $1.63M | 0.04% | 00.0% | Unchanged |
| Exos TFP Holdings LLC | 150,000 | $1.63M | 1.01% | 00.0% | Unchanged |
| P Schoenfeld Asset Management LP | 133,234 | $1.45M | 0.40% | 00.0% | Unchanged |
| Vivaldi Asset Management, LLC | 128,449 | $1.40M | 0.11% | 00.0% | Unchanged |
| Radcliffe Capital Management, L.P. | 102,184 | $1.11M | 0.15% | +490+0.5% | Added |
| Shaolin Capital Management LLC | 63,251 | $688.8K | 0.02% | −20,000−24.0% | Reduced |
| Westchester Capital Management, LLC | 36,029 | $393.1K | 0.02% | 00.0% | Unchanged |
| Glazer Capital, LLC | 30,639 | $334.0K | 0.03% | +30,639 | New |
| Tuttle Tactical Management | 17,000 | $185.1K | 1.29% | +17,000 | New |
| Robinson Capital Management, LLC | 10,482 | $114.0K | 0.04% | −768−6.8% | Reduced |
| Toroso Investments, LLC | 10,431 | $113.8K | 0.00% | −768−6.9% | Reduced |
| Quarry LP | 1,200 | $13.1K | 0.01% | +928+341.2% | Added |
| Sea Otter Advisors LLC | 1,120 | $12.2K | 0.01% | −332−22.9% | Reduced |
| BlackRock Inc. | 300 | $3.27K | 0.00% | +300 | New |
| Elequin Capital LP | 10 | $109 | 0.00% | 00.0% | Unchanged |
| Cohanzick Management, LLC | 83,333 | $0 | 0.00% | 00.0% | Unchanged |
| Mizuho Securities USA LLC | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −8−100.0% | Sold out |